ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.
Monday 13 October 2025
scmp - 5 month ago
Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund

⁞
